Complications Associated with Erythropoietin Stimulating Agents (ESAs) in Patients with Metastatic Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER)-Medicare Study

類似資料

• Surveillance, Epidemiology, and End Results (SEER) and SEER-Medicare Databases: Use in Clinical Research for Improving Colorectal Cancer Outcomes
  著者:: Daly, Meghan C., 等
  出版事項: (2019)
• Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer
  著者:: Srokowski, Tomasz P., 等
  出版事項: (2009)
• Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)–Medicare investigation of treatment patterns and overall survival
  著者:: Beebe-Dimmer, Jennifer L, 等
  出版事項: (2016)
• Real‐World Patterns of Everolimus Use in Patients with Metastatic Breast Cancer
  著者:: Sharma, Manvi, 等
  出版事項: (2020)
• First-line treatment in older patients with Hodgkin lymphoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare population-based study
  著者:: Rodday, Angie Mae, 等
  出版事項: (2020)